

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.89984330 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.54621125 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.54621125 |
| 4 | exogenous drug catabolic process (GO:0042738) | 7.48104992 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.23022676 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.23022676 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 7.06256356 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.80964246 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.34288673 |
| 10 | drug metabolic process (GO:0017144) | 6.30734385 |
| 11 | phenylpropanoid metabolic process (GO:0009698) | 6.23817284 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.17613254 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 6.17613254 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 6.17613254 |
| 15 | kynurenine metabolic process (GO:0070189) | 6.03905321 |
| 16 | oxidative demethylation (GO:0070989) | 6.02845354 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.96133590 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.81521769 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.81136814 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.79714051 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.68789819 |
| 22 | urea metabolic process (GO:0019627) | 5.64969171 |
| 23 | urea cycle (GO:0000050) | 5.64969171 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.58900901 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.56316723 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.56247446 |
| 27 | protein carboxylation (GO:0018214) | 5.50745460 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.50745460 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.48971038 |
| 30 | alpha-linolenic acid metabolic process (GO:0036109) | 5.38684057 |
| 31 | cysteine metabolic process (GO:0006534) | 5.38143120 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.19480361 |
| 33 | regulation of complement activation (GO:0030449) | 5.18854841 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 5.15124677 |
| 35 | bile acid metabolic process (GO:0008206) | 5.09444322 |
| 36 | regulation of plasminogen activation (GO:0010755) | 5.06397997 |
| 37 | ethanol metabolic process (GO:0006067) | 5.04385280 |
| 38 | negative regulation of blood coagulation (GO:0030195) | 4.99827201 |
| 39 | negative regulation of hemostasis (GO:1900047) | 4.99827201 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.95914105 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.94366424 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.93418330 |
| 43 | alkaloid metabolic process (GO:0009820) | 4.85510883 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.83361972 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.82352613 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.82352613 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.82352613 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.77566636 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.77120925 |
| 50 | homocysteine metabolic process (GO:0050667) | 4.66459419 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.64585480 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.64585480 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.61498714 |
| 54 | negative regulation of wound healing (GO:0061045) | 4.60859604 |
| 55 | phospholipid efflux (GO:0033700) | 4.59297324 |
| 56 | hormone catabolic process (GO:0042447) | 4.59268406 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 4.56673332 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.54549992 |
| 59 | negative regulation of sterol transport (GO:0032372) | 4.54549992 |
| 60 | negative regulation of coagulation (GO:0050819) | 4.54484530 |
| 61 | lysine metabolic process (GO:0006553) | 4.53767998 |
| 62 | lysine catabolic process (GO:0006554) | 4.53767998 |
| 63 | steroid catabolic process (GO:0006706) | 4.45170815 |
| 64 | glycine metabolic process (GO:0006544) | 4.41707200 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 4.37948835 |
| 66 | cellular glucuronidation (GO:0052695) | 4.37354406 |
| 67 | cellular ketone body metabolic process (GO:0046950) | 4.36285090 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 4.36249372 |
| 69 | coenzyme catabolic process (GO:0009109) | 4.36078838 |
| 70 | bile acid and bile salt transport (GO:0015721) | 4.35919100 |
| 71 | indolalkylamine metabolic process (GO:0006586) | 4.35734568 |
| 72 | negative regulation of complement activation (GO:0045916) | 4.34970540 |
| 73 | regulation of humoral immune response (GO:0002920) | 4.29004800 |
| 74 | ethanol oxidation (GO:0006069) | 4.28722846 |
| 75 | cellular biogenic amine catabolic process (GO:0042402) | 4.27848634 |
| 76 | amine catabolic process (GO:0009310) | 4.27848634 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 4.25427457 |
| 78 | cholesterol efflux (GO:0033344) | 4.25275216 |
| 79 | glutamate metabolic process (GO:0006536) | 4.19566544 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 4.17004152 |
| 81 | fibrinolysis (GO:0042730) | 4.16780588 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 4.15901047 |
| 83 | positive regulation of hemostasis (GO:1900048) | 4.10127344 |
| 84 | positive regulation of blood coagulation (GO:0030194) | 4.10127344 |
| 85 | aldehyde catabolic process (GO:0046185) | 4.06356745 |
| 86 | arginine metabolic process (GO:0006525) | 4.04595515 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 4.04276819 |
| 88 | S-adenosylmethionine metabolic process (GO:0046500) | 4.00542815 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 3.97474054 |
| 90 | plasma lipoprotein particle assembly (GO:0034377) | 3.97159592 |
| 91 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96736659 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.95409078 |
| 93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.94151557 |
| 94 | complement activation, classical pathway (GO:0006958) | 3.93856908 |
| 95 | uronic acid metabolic process (GO:0006063) | 3.91666972 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.91666972 |
| 97 | drug catabolic process (GO:0042737) | 3.90608667 |
| 98 | complement activation (GO:0006956) | 3.87674119 |
| 99 | protein activation cascade (GO:0072376) | 3.86025576 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.84612399 |
| 101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.84612399 |
| 102 | flavonoid metabolic process (GO:0009812) | 3.82952568 |
| 103 | negative regulation of lipase activity (GO:0060192) | 3.81438346 |
| 104 | positive regulation of coagulation (GO:0050820) | 3.79860941 |
| 105 | cofactor catabolic process (GO:0051187) | 3.79751513 |
| 106 | cytolysis (GO:0019835) | 3.77796583 |
| 107 | ketone body metabolic process (GO:1902224) | 3.77238721 |
| 108 | regulation of bile acid biosynthetic process (GO:0070857) | 3.75128266 |
| 109 | acute-phase response (GO:0006953) | 3.73289167 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.72684490 |
| 111 | organic acid catabolic process (GO:0016054) | 3.71156025 |
| 112 | carboxylic acid catabolic process (GO:0046395) | 3.71156025 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 3.69621556 |
| 114 | phospholipid homeostasis (GO:0055091) | 3.68960077 |
| 115 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.68163615 |
| 116 | xenobiotic metabolic process (GO:0006805) | 3.67141645 |
| 117 | sterol homeostasis (GO:0055092) | 3.66505781 |
| 118 | regulation of cholesterol homeostasis (GO:2000188) | 3.65034328 |
| 119 | negative regulation of protein activation cascade (GO:2000258) | 3.64618758 |
| 120 | plasma lipoprotein particle organization (GO:0071827) | 3.64572981 |
| 121 | regulation of lipoprotein particle clearance (GO:0010984) | 3.63406188 |
| 122 | heme transport (GO:0015886) | 3.62386502 |
| 123 | short-chain fatty acid metabolic process (GO:0046459) | 3.61693375 |
| 124 | opsonization (GO:0008228) | 3.60291007 |
| 125 | acute inflammatory response (GO:0002526) | 3.51444386 |
| 126 | cholesterol catabolic process (GO:0006707) | 3.45762336 |
| 127 | sterol catabolic process (GO:0016127) | 3.45762336 |
| 128 | drug transmembrane transport (GO:0006855) | 3.45153390 |
| 129 | negative regulation of humoral immune response (GO:0002921) | 3.44148880 |
| 130 | proline metabolic process (GO:0006560) | 3.42804903 |
| 131 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.41437228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.36785615 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.16111305 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.97578352 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.44943067 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.29009275 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.20310216 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.86062421 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.10095642 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98287238 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05075066 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9853061 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93883697 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.93205644 |
| 14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58734807 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52259221 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.51581447 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39725507 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37979598 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35011536 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.28061377 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27464131 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21027564 |
| 23 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20635646 |
| 24 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20313194 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17900387 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.16698414 |
| 27 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07665074 |
| 28 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.05663832 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02399214 |
| 30 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.98531779 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98488505 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98404831 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97694441 |
| 34 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.96921094 |
| 35 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95242181 |
| 36 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90969528 |
| 37 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.90949700 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90806358 |
| 39 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.90145223 |
| 40 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.88173249 |
| 41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85942099 |
| 42 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.85706182 |
| 43 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85271915 |
| 44 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.84005629 |
| 45 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.83286066 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82807273 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81075878 |
| 48 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80802753 |
| 49 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80700085 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.80003343 |
| 51 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77856696 |
| 52 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.77747595 |
| 53 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77525133 |
| 54 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76919368 |
| 55 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.76448983 |
| 56 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75809060 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.74384291 |
| 58 | NFYA_21822215_ChIP-Seq_K562_Human | 0.74164818 |
| 59 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.74162390 |
| 60 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.73876376 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72048195 |
| 62 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.71859958 |
| 63 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.71286744 |
| 64 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.70488707 |
| 65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69892665 |
| 66 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.69415959 |
| 67 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.69079039 |
| 68 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.67879510 |
| 69 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67316142 |
| 70 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.67261349 |
| 71 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66758142 |
| 72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.65929043 |
| 73 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65759506 |
| 74 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.65469392 |
| 75 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.65314753 |
| 76 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.65033015 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65007827 |
| 78 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64951733 |
| 79 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64618610 |
| 80 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.63851535 |
| 81 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.63467794 |
| 82 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.63296182 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.63161000 |
| 84 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.62035758 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.61017997 |
| 86 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.60470123 |
| 87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60342928 |
| 88 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.60171372 |
| 89 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.60006966 |
| 90 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.59985059 |
| 91 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.59731582 |
| 92 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59719113 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.58303616 |
| 94 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.58110021 |
| 95 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58025712 |
| 96 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58025712 |
| 97 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.57963305 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57810154 |
| 99 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.57723984 |
| 100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.57203959 |
| 101 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.56826481 |
| 102 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.56552275 |
| 103 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.56522024 |
| 104 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.56279823 |
| 105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.55409569 |
| 106 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54685375 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.54520823 |
| 108 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54405288 |
| 109 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53783887 |
| 110 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53027628 |
| 111 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51038163 |
| 112 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50257359 |
| 113 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.49567788 |
| 114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.48706047 |
| 115 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48601657 |
| 116 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46808198 |
| 117 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46258668 |
| 118 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45469534 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.45186810 |
| 120 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.44706071 |
| 121 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.43965279 |
| 122 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43272400 |
| 123 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42685032 |
| 124 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41960846 |
| 125 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41542095 |
| 126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41346652 |
| 127 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41338062 |
| 128 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41309558 |
| 129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.40989412 |
| 130 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.40786621 |
| 131 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40633948 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39863402 |
| 133 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39746782 |
| 134 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.38638357 |
| 135 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.37980076 |
| 136 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.36976797 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.36975083 |
| 138 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.36902339 |
| 139 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.36392272 |
| 140 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.35567710 |
| 141 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.35514251 |
| 142 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35254595 |
| 143 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34835884 |
| 144 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34578490 |
| 145 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.34564563 |
| 146 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.34529270 |
| 147 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.34253593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.24547709 |
| 2 | MP0005360_urolithiasis | 7.52016852 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.45131776 |
| 4 | MP0005365_abnormal_bile_salt | 6.16550634 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.28224988 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.41261611 |
| 7 | MP0003252_abnormal_bile_duct | 3.86403704 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.58614155 |
| 9 | MP0009840_abnormal_foam_cell | 3.33384937 |
| 10 | MP0005083_abnormal_biliary_tract | 3.08620295 |
| 11 | MP0003195_calcinosis | 2.83255972 |
| 12 | MP0005332_abnormal_amino_acid | 2.71885640 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58071031 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.45984384 |
| 15 | MP0000609_abnormal_liver_physiology | 2.15631571 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.12504813 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.06961826 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.88457224 |
| 19 | MP0003868_abnormal_feces_composition | 1.86735831 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83861718 |
| 21 | MP0001764_abnormal_homeostasis | 1.65272668 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56487003 |
| 23 | MP0009697_abnormal_copulation | 1.56384823 |
| 24 | MP0003011_delayed_dark_adaptation | 1.39138941 |
| 25 | MP0005451_abnormal_body_composition | 1.38537300 |
| 26 | MP0003186_abnormal_redox_activity | 1.32327607 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.26934870 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.21791191 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.19750466 |
| 30 | MP0000598_abnormal_liver_morphology | 1.17891453 |
| 31 | MP0005647_abnormal_sex_gland | 1.16352808 |
| 32 | MP0005187_abnormal_penis_morphology | 1.13487404 |
| 33 | MP0000604_amyloidosis | 1.09662435 |
| 34 | MP0009764_decreased_sensitivity_to | 1.06396874 |
| 35 | MP0002254_reproductive_system_inflammat | 1.04867104 |
| 36 | MP0009763_increased_sensitivity_to | 1.03427174 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.01124578 |
| 38 | MP0001915_intracranial_hemorrhage | 0.97669551 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.90000621 |
| 40 | MP0008469_abnormal_protein_level | 0.87744040 |
| 41 | MP0005408_hypopigmentation | 0.86512711 |
| 42 | MP0009642_abnormal_blood_homeostasis | 0.85868433 |
| 43 | MP0005376_homeostasis/metabolism_phenot | 0.81105295 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 0.80327221 |
| 45 | MP0009765_abnormal_xenobiotic_induced | 0.78863381 |
| 46 | MP0002090_abnormal_vision | 0.77788205 |
| 47 | MP0005670_abnormal_white_adipose | 0.77336498 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.74673981 |
| 49 | MP0005220_abnormal_exocrine_pancreas | 0.74313144 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 0.73246411 |
| 51 | MP0010386_abnormal_urinary_bladder | 0.72805010 |
| 52 | MP0002876_abnormal_thyroid_physiology | 0.71690886 |
| 53 | MP0002971_abnormal_brown_adipose | 0.70964413 |
| 54 | MP0009053_abnormal_anal_canal | 0.70499494 |
| 55 | MP0005266_abnormal_metabolism | 0.67614083 |
| 56 | MP0005058_abnormal_lysosome_morphology | 0.66094230 |
| 57 | MP0001661_extended_life_span | 0.65895107 |
| 58 | MP0005334_abnormal_fat_pad | 0.64938868 |
| 59 | MP0003879_abnormal_hair_cell | 0.64895249 |
| 60 | MP0003690_abnormal_glial_cell | 0.64187801 |
| 61 | MP0004130_abnormal_muscle_cell | 0.63283017 |
| 62 | MP0005535_abnormal_body_temperature | 0.62537060 |
| 63 | MP0000639_abnormal_adrenal_gland | 0.61737714 |
| 64 | MP0003329_amyloid_beta_deposits | 0.60822737 |
| 65 | MP0001756_abnormal_urination | 0.55608851 |
| 66 | MP0002282_abnormal_trachea_morphology | 0.54156859 |
| 67 | MP0006035_abnormal_mitochondrial_morpho | 0.54044888 |
| 68 | MP0005395_other_phenotype | 0.53848328 |
| 69 | MP0005448_abnormal_energy_balance | 0.53185985 |
| 70 | MP0003718_maternal_effect | 0.53053379 |
| 71 | MP0005464_abnormal_platelet_physiology | 0.52944028 |
| 72 | MP0002822_catalepsy | 0.48852304 |
| 73 | MP0004782_abnormal_surfactant_physiolog | 0.47181690 |
| 74 | MP0005248_abnormal_Harderian_gland | 0.46524168 |
| 75 | MP0002928_abnormal_bile_duct | 0.45825365 |
| 76 | MP0008874_decreased_physiological_sensi | 0.45483473 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 0.45081741 |
| 78 | MP0008873_increased_physiological_sensi | 0.44443683 |
| 79 | MP0003638_abnormal_response/metabolism_ | 0.43820293 |
| 80 | MP0002136_abnormal_kidney_physiology | 0.43132934 |
| 81 | MP0001984_abnormal_olfaction | 0.43082044 |
| 82 | MP0003075_altered_response_to | 0.42816067 |
| 83 | MP0002249_abnormal_larynx_morphology | 0.41473355 |
| 84 | MP0003436_decreased_susceptibility_to | 0.41228971 |
| 85 | MP0000579_abnormal_nail_morphology | 0.40597150 |
| 86 | MP0005166_decreased_susceptibility_to | 0.39181431 |
| 87 | MP0003953_abnormal_hormone_level | 0.38905438 |
| 88 | MP0008872_abnormal_physiological_respon | 0.38816410 |
| 89 | MP0002796_impaired_skin_barrier | 0.38422285 |
| 90 | MP0004381_abnormal_hair_follicle | 0.37766563 |
| 91 | MP0003724_increased_susceptibility_to | 0.36342129 |
| 92 | MP0009785_altered_susceptibility_to | 0.36121170 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.35539356 |
| 94 | MP0002837_dystrophic_cardiac_calcinosis | 0.34762147 |
| 95 | MP0006082_CNS_inflammation | 0.33547835 |
| 96 | MP0009115_abnormal_fat_cell | 0.32974551 |
| 97 | MP0004883_abnormal_blood_vessel | 0.32758147 |
| 98 | MP0009672_abnormal_birth_weight | 0.32631807 |
| 99 | MP0000249_abnormal_blood_vessel | 0.32487779 |
| 100 | MP0002132_abnormal_respiratory_system | 0.32115647 |
| 101 | MP0002168_other_aberrant_phenotype | 0.31518154 |
| 102 | MP0002970_abnormal_white_adipose | 0.29715404 |
| 103 | MP0001243_abnormal_dermal_layer | 0.29375036 |
| 104 | MP0005197_abnormal_uvea_morphology | 0.28598288 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.28436700 |
| 106 | MP0009384_cardiac_valve_regurgitation | 0.26908721 |
| 107 | MP0004264_abnormal_extraembryonic_tissu | 0.25853589 |
| 108 | MP0005164_abnormal_response_to | 0.25808852 |
| 109 | MP0003941_abnormal_skin_development | 0.25771044 |
| 110 | MP0001845_abnormal_inflammatory_respons | 0.25743166 |
| 111 | MP0001881_abnormal_mammary_gland | 0.25601133 |
| 112 | MP0000230_abnormal_systemic_arterial | 0.25462945 |
| 113 | MP0002060_abnormal_skin_morphology | 0.25429021 |
| 114 | MP0005023_abnormal_wound_healing | 0.23819276 |
| 115 | MP0001986_abnormal_taste_sensitivity | 0.22633231 |
| 116 | MP0000467_abnormal_esophagus_morphology | 0.20665809 |
| 117 | MP0003959_abnormal_lean_body | 0.19955796 |
| 118 | MP0000920_abnormal_myelination | 0.17099665 |
| 119 | MP0000566_synostosis | 0.16855171 |
| 120 | MP0002697_abnormal_eye_size | 0.15800734 |
| 121 | MP0001440_abnormal_grooming_behavior | 0.14839657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.59302035 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.42815622 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.34138800 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.71052857 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.70679402 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.39968488 |
| 7 | Xanthomatosis (HP:0000991) | 6.22887690 |
| 8 | Complement deficiency (HP:0004431) | 5.71623138 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.64443555 |
| 10 | Joint hemorrhage (HP:0005261) | 4.94403900 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.85819686 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.65254631 |
| 13 | Hyperammonemia (HP:0001987) | 4.59716562 |
| 14 | Hyperglycinemia (HP:0002154) | 4.48561690 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.42200399 |
| 16 | Epidermoid cyst (HP:0200040) | 4.36119862 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.31188450 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.28773674 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26834255 |
| 20 | Ketosis (HP:0001946) | 4.21453990 |
| 21 | Abnormality of complement system (HP:0005339) | 4.18696849 |
| 22 | Fat malabsorption (HP:0002630) | 4.13597781 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.10998575 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.04723024 |
| 25 | Reduced antithrombin III activity (HP:0001976) | 4.03421855 |
| 26 | Hyperglycinuria (HP:0003108) | 3.91053284 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.89418960 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.89418960 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.85904226 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.83378471 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.73436068 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.67702841 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.57668409 |
| 34 | Osteomalacia (HP:0002749) | 3.34261947 |
| 35 | Spontaneous abortion (HP:0005268) | 3.33592542 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.31809861 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.29411411 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.28394607 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 3.18811095 |
| 40 | Steatorrhea (HP:0002570) | 3.17175426 |
| 41 | Delayed CNS myelination (HP:0002188) | 3.12308820 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.06874250 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04579658 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 3.03943450 |
| 45 | Myocardial infarction (HP:0001658) | 2.96472044 |
| 46 | Ketoacidosis (HP:0001993) | 2.93179706 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.84158268 |
| 48 | Metabolic acidosis (HP:0001942) | 2.75192247 |
| 49 | Skin nodule (HP:0200036) | 2.66699989 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.65180252 |
| 51 | Glomerulonephritis (HP:0000099) | 2.61845622 |
| 52 | Lethargy (HP:0001254) | 2.61024602 |
| 53 | Vascular calcification (HP:0004934) | 2.60174716 |
| 54 | Arthropathy (HP:0003040) | 2.55346074 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.54255396 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.54255396 |
| 57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52637038 |
| 58 | Spastic diplegia (HP:0001264) | 2.50828078 |
| 59 | Purpura (HP:0000979) | 2.49884190 |
| 60 | Amyloidosis (HP:0011034) | 2.49854365 |
| 61 | Abnormality of the Achilles tendon (HP:0005109) | 2.48721416 |
| 62 | Gout (HP:0001997) | 2.47726960 |
| 63 | Abnormal gallbladder morphology (HP:0012437) | 2.42948399 |
| 64 | Neonatal onset (HP:0003623) | 2.40729993 |
| 65 | Acanthocytosis (HP:0001927) | 2.38904524 |
| 66 | Cerebral edema (HP:0002181) | 2.38506090 |
| 67 | Hyperphosphaturia (HP:0003109) | 2.38077600 |
| 68 | Cholelithiasis (HP:0001081) | 2.37920176 |
| 69 | Mitral stenosis (HP:0001718) | 2.36212043 |
| 70 | Gingival bleeding (HP:0000225) | 2.35732924 |
| 71 | Fair hair (HP:0002286) | 2.35386384 |
| 72 | Hypoglycemic seizures (HP:0002173) | 2.34975325 |
| 73 | Irritability (HP:0000737) | 2.33900114 |
| 74 | Cholecystitis (HP:0001082) | 2.32822697 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.32822697 |
| 76 | Cardiovascular calcification (HP:0011915) | 2.30225774 |
| 77 | Esophageal varix (HP:0002040) | 2.26977312 |
| 78 | Malnutrition (HP:0004395) | 2.26860387 |
| 79 | Menorrhagia (HP:0000132) | 2.19930063 |
| 80 | Thrombophlebitis (HP:0004418) | 2.19443277 |
| 81 | Glycosuria (HP:0003076) | 2.19427096 |
| 82 | Abnormality of urine glucose concentration (HP:0011016) | 2.19427096 |
| 83 | Neonatal hypoglycemia (HP:0001998) | 2.18739514 |
| 84 | Elevated alkaline phosphatase (HP:0003155) | 2.14114173 |
| 85 | Pancreatitis (HP:0001733) | 2.14100320 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.11835654 |
| 87 | Enlarged kidneys (HP:0000105) | 2.11656979 |
| 88 | Late onset (HP:0003584) | 2.09104905 |
| 89 | Vomiting (HP:0002013) | 2.07057713 |
| 90 | Opisthotonus (HP:0002179) | 2.05004676 |
| 91 | Brushfield spots (HP:0001088) | 2.04800768 |
| 92 | Poikilocytosis (HP:0004447) | 2.02863135 |
| 93 | Hemorrhage of the eye (HP:0011885) | 2.02632471 |
| 94 | Bile duct proliferation (HP:0001408) | 2.00436746 |
| 95 | Abnormal biliary tract physiology (HP:0012439) | 2.00436746 |
| 96 | Abnormality of the gallbladder (HP:0005264) | 1.98200821 |
| 97 | Increased serum ferritin (HP:0003281) | 1.96275081 |
| 98 | Generalized aminoaciduria (HP:0002909) | 1.95582556 |
| 99 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.95385041 |
| 100 | Gangrene (HP:0100758) | 1.94229376 |
| 101 | Rickets (HP:0002748) | 1.93737170 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 1.91289649 |
| 103 | Atrioventricular block (HP:0001678) | 1.91205928 |
| 104 | Abnormal urine phosphate concentration (HP:0012599) | 1.90544959 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89425020 |
| 106 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.87543021 |
| 107 | Hypophosphatemic rickets (HP:0004912) | 1.87157936 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 1.85330511 |
| 109 | Nephritis (HP:0000123) | 1.84386723 |
| 110 | Renal cortical cysts (HP:0000803) | 1.81616922 |
| 111 | Elevated hepatic transaminases (HP:0002910) | 1.80094330 |
| 112 | Status epilepticus (HP:0002133) | 1.79657546 |
| 113 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78755447 |
| 114 | Alkalosis (HP:0001948) | 1.78406213 |
| 115 | Abnormality of proline metabolism (HP:0010907) | 1.75777956 |
| 116 | Hydroxyprolinuria (HP:0003080) | 1.75777956 |
| 117 | Lower limb hyperreflexia (HP:0002395) | 1.74093892 |
| 118 | Abnormality of vitamin metabolism (HP:0100508) | 1.72235408 |
| 119 | Pulmonary embolism (HP:0002204) | 1.71974776 |
| 120 | Abnormal pupillary function (HP:0007686) | 1.69340201 |
| 121 | Retinal atrophy (HP:0001105) | 1.69239822 |
| 122 | Hypophosphatemia (HP:0002148) | 1.62987999 |
| 123 | Decreased subcutaneous fat (HP:0001002) | 1.62337355 |
| 124 | Generalized hypopigmentation of hair (HP:0011358) | 1.61026993 |
| 125 | Achilles tendon contracture (HP:0001771) | 1.58608528 |
| 126 | Bifid scrotum (HP:0000048) | 1.57840155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.25510682 |
| 2 | ERN1 | 4.78492499 |
| 3 | FGFR4 | 4.69279461 |
| 4 | SIK1 | 4.33370152 |
| 5 | TAOK3 | 3.01121618 |
| 6 | ERBB4 | 2.95672296 |
| 7 | INSRR | 2.71446454 |
| 8 | PIK3CA | 2.64922038 |
| 9 | MAP2K4 | 2.32431875 |
| 10 | PKN2 | 2.10262994 |
| 11 | TRIB3 | 2.04430947 |
| 12 | MST1R | 2.04278885 |
| 13 | MAPK11 | 1.91570436 |
| 14 | LATS1 | 1.77326922 |
| 15 | PIK3CG | 1.72012738 |
| 16 | FLT3 | 1.71308569 |
| 17 | PDK2 | 1.65543282 |
| 18 | TYK2 | 1.59045997 |
| 19 | PRPF4B | 1.57176198 |
| 20 | DAPK2 | 1.55505025 |
| 21 | PTK6 | 1.45076917 |
| 22 | PRKG1 | 1.44143681 |
| 23 | TESK2 | 1.44010287 |
| 24 | MAP3K12 | 1.42707907 |
| 25 | ABL2 | 1.40568816 |
| 26 | WNK3 | 1.39310827 |
| 27 | NTRK3 | 1.36818156 |
| 28 | STK16 | 1.35250586 |
| 29 | NEK9 | 1.33964232 |
| 30 | FRK | 1.25262758 |
| 31 | FGFR2 | 1.22837191 |
| 32 | MYLK | 1.20890545 |
| 33 | MAPK15 | 1.20712637 |
| 34 | PINK1 | 1.19563586 |
| 35 | KDR | 1.18173658 |
| 36 | MAP3K7 | 1.17022394 |
| 37 | CSNK1D | 1.16995328 |
| 38 | GRK6 | 1.16961022 |
| 39 | PRKACA | 1.15775320 |
| 40 | TNK2 | 1.15034515 |
| 41 | JAK2 | 1.14418497 |
| 42 | STK38L | 1.13575902 |
| 43 | MAP2K3 | 1.09228419 |
| 44 | PRKAA2 | 1.08157907 |
| 45 | ERBB2 | 1.04860581 |
| 46 | SGK1 | 1.00202095 |
| 47 | PRKCB | 0.98412983 |
| 48 | TBK1 | 0.96174425 |
| 49 | CDK6 | 0.93794944 |
| 50 | MAP3K10 | 0.92408260 |
| 51 | MAPK4 | 0.92018740 |
| 52 | PRKCZ | 0.91464302 |
| 53 | MAP3K3 | 0.91072322 |
| 54 | JAK1 | 0.89319717 |
| 55 | EPHB1 | 0.85783036 |
| 56 | MUSK | 0.84957705 |
| 57 | MAP3K11 | 0.84699847 |
| 58 | CAMK2G | 0.83279883 |
| 59 | EPHA3 | 0.82781568 |
| 60 | BLK | 0.82705307 |
| 61 | MAP3K14 | 0.81987777 |
| 62 | MAPK12 | 0.81546360 |
| 63 | DYRK1B | 0.80425033 |
| 64 | MET | 0.77616079 |
| 65 | EIF2AK3 | 0.76766400 |
| 66 | SCYL2 | 0.75863432 |
| 67 | TIE1 | 0.75737379 |
| 68 | ARAF | 0.74792749 |
| 69 | RPS6KA3 | 0.74275335 |
| 70 | PIM2 | 0.74182165 |
| 71 | PRKACG | 0.72980975 |
| 72 | ZAP70 | 0.72201227 |
| 73 | CSK | 0.71227946 |
| 74 | MAP2K6 | 0.70216368 |
| 75 | RIPK1 | 0.69778668 |
| 76 | SGK3 | 0.66923073 |
| 77 | GSK3A | 0.65695303 |
| 78 | ICK | 0.65333867 |
| 79 | MAP3K2 | 0.65290801 |
| 80 | CSNK2A2 | 0.64321087 |
| 81 | PRKAA1 | 0.64063066 |
| 82 | TGFBR2 | 0.62739279 |
| 83 | MAPK7 | 0.62609073 |
| 84 | PRKACB | 0.62543030 |
| 85 | CAMK1D | 0.61212963 |
| 86 | CAMKK1 | 0.59818570 |
| 87 | SRC | 0.58177453 |
| 88 | CSNK1A1 | 0.57941097 |
| 89 | FGFR3 | 0.56755293 |
| 90 | PTK2 | 0.56220065 |
| 91 | CSNK2A1 | 0.56217026 |
| 92 | MAP3K6 | 0.55046581 |
| 93 | IRAK3 | 0.54991620 |
| 94 | CSNK1G1 | 0.53968816 |
| 95 | EIF2AK1 | 0.53560096 |
| 96 | SGK2 | 0.50730592 |
| 97 | STK38 | 0.49332216 |
| 98 | IKBKE | 0.48128649 |
| 99 | PDPK1 | 0.46922511 |
| 100 | CASK | 0.45144697 |
| 101 | PRKCQ | 0.44795330 |
| 102 | MAP2K1 | 0.44702712 |
| 103 | PRKCE | 0.44616155 |
| 104 | CSF1R | 0.44590227 |
| 105 | CSNK1E | 0.43588897 |
| 106 | CAMKK2 | 0.43251761 |
| 107 | GRK1 | 0.42331623 |
| 108 | PRKCG | 0.42008175 |
| 109 | MAP3K5 | 0.41130694 |
| 110 | CDK4 | 0.40335740 |
| 111 | MAPK3 | 0.39533947 |
| 112 | TAOK2 | 0.39253510 |
| 113 | IGF1R | 0.37471310 |
| 114 | MTOR | 0.37044368 |
| 115 | LATS2 | 0.36778815 |
| 116 | CAMK4 | 0.36245037 |
| 117 | MAPK10 | 0.36227348 |
| 118 | PAK3 | 0.35675016 |
| 119 | SGK223 | 0.34976695 |
| 120 | SGK494 | 0.34976695 |
| 121 | EGFR | 0.34587566 |
| 122 | RET | 0.34173717 |
| 123 | PKN1 | 0.33775561 |
| 124 | MAP2K2 | 0.33191079 |
| 125 | CSNK1G3 | 0.32707911 |
| 126 | EPHA4 | 0.32516935 |
| 127 | PBK | 0.31647763 |
| 128 | CSNK1G2 | 0.30418849 |
| 129 | IRAK1 | 0.27805351 |
| 130 | AKT3 | 0.26222652 |
| 131 | CSNK1A1L | 0.25743328 |
| 132 | PRKCA | 0.24765971 |
| 133 | BMX | 0.23038571 |
| 134 | MAP3K1 | 0.22225446 |
| 135 | PDK1 | 0.21999787 |
| 136 | ABL1 | 0.21524741 |
| 137 | MAP3K13 | 0.20954611 |
| 138 | IRAK2 | 0.19581142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.56278693 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45395556 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38781146 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.38045967 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07156289 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.88767544 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65352326 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62482474 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57752602 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53988294 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45443489 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33798506 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.31163524 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.22692221 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10858353 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.04508612 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.03774583 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.02801051 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.99067628 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92529087 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.87696949 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82665608 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81804257 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79962083 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75866653 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74131356 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73460442 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72773942 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71815819 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65593032 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59145888 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58635903 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53919538 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52202805 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52019137 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.50976961 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.48950134 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39810283 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35057079 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33698336 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28981918 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24396353 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23167995 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21133324 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19946062 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.18477707 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14893598 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09857298 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06731111 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03680843 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00357765 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98759269 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97899710 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95893595 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95293044 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87691470 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83512724 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83045651 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.77319508 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77034309 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72540566 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69917985 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64117825 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56754634 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51244227 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45740845 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43421173 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.41151435 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34887026 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.29396226 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26153565 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24187438 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24093940 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23540042 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.22486705 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20855005 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17614266 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14498097 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09397389 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.09194322 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01310704 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2421041 |
| 83 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.2307391 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2288365 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | -0.2275150 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2268340 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2206552 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2175455 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2052775 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2024936 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1961859 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1820817 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1693290 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1693273 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1632552 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1615692 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1519209 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1444748 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1239847 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1205025 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1195344 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1053351 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0829268 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | -0.0825645 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0812572 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0662195 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0523103 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0346777 |
| 109 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0051467 |

